期刊文献+

慢性阻塞性肺疾病药物研究进展 被引量:3

Research progress of drugs for chronic obstructive pulmonary disease
下载PDF
导出
摘要 慢性阻塞性肺疾病(COPD)是一种常见病,在世界范围内发病率逐年上升。现对其防治药物,如支气管扩张剂、糖皮质激素、磷酸二酯酶4(PDE4)抑制剂、炎症介质阻滞剂、蛋白酶抑制剂、黏液调整剂等研究进展做一综述。 Chronic obstructive pulmonary disease (COPD) is a common disease and its worldwide incidence has been increasing year after year. In this paper, the research progress of drugs for treatment and prevention of COPD, including bronchodilators, glucocorticoids, phosphodiesterase type 4 inhibitors,inhibitors of inflammatory mediators,protease inhibitors and mucoregulators are reviewed.
出处 《中国新药杂志》 CAS CSCD 北大核心 2004年第4期295-300,共6页 Chinese Journal of New Drugs
关键词 慢性阻塞性肺疾病 支气管扩张剂 糖皮质激素 磷酸二酯晦4(PDE4) 炎症介质阻滞剂 蛋白晦 抑制剂 黏液调整剂 chronic obstructive pulmonary disease bronchodilator glucocorticoids phosphodi-esterase type 4 inhibitors inhibitors of inflammatory mediators protease inhibitors mucoregulators
  • 相关文献

参考文献30

  • 1Viegi G, Scognamiglio A, Baldacci S, et al. Epidemiology of chronic obstructive pulmonary disease (COPD) [J]. Respiration, 2001,68(1) :4 - 19. 被引量:1
  • 2Peter JB. New therapies for chronic obstructive pulmonary disease [J]. Thorax, 1998,53(2): 137 - 147. 被引量:1
  • 3Rennard SI, Serby CW, Ghafouri M, et al. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials[J]. Chest, 1996,110(1): 62 - 70. 被引量:1
  • 4Hvizdos KM,Goa KL.Tiotropium bromide[J]. Drugs,2002,62(8): 1195 - 1203. 被引量:1
  • 5Haddad E, Mak JCW, Barnes PJ. Characterization of [3H] Ba 679,a slow-dissociating muscarinic receptor antagonist in human lung:radioligand binding and autoradiographic mapping[J]. Mol Pharmacol, 1994,45 (5) :899 - 907. 被引量:1
  • 6Barnes PJ,Belvisi MG,Mak JCW,et al.Tiotropium bromide(Ba 679 BR) ,a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease[J]. Life Sci, 1995,56(11-12) :853 - 859. 被引量:1
  • 7Disse B,Speck GA,Rominger KL,et al. Tiotropium (Spiriva):mechanistical consideration and clinical profile in obstructive lung disease[J]. Life Sci ,1999,64(6) :457 - 464. 被引量:1
  • 8Casaburi R, Mahler DA,Jones PW, et al. A long-term evaluation of once-daily tiotropium in COPD [J]. Eur Respir J, 2002, 19(2) :217 - 224. 被引量:1
  • 9Noord JA,Munck DR,Bantje TA,et al. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium [J]. Eur Respir J, 2000,15 (5):878 - 885. 被引量:1
  • 10Zuwallack RL, Mahler DA, Reilly D, et al. Salmeterol plus theophylline combination therapy in the treatment of COPD [J].Chest ,2001,119(6): 1661 - 1670. 被引量:1

同被引文献10

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部